NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
Clinical Trials
12 trialsNCT05235542 2022-08-11
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
Akeso
Phase 1/2 Unknown
NCT05173142 2022-03-08
HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors
Hutchmed
Phase 1/2 Unknown
NCT03726736 2019-06-07
ACWDVDFPTAN
Sir Run Run Shaw Hospital
Phase 1/2 Unknown
NCT02884479 2018-04-25
An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study
SciClone Pharmaceuticals
Phase 1/2 Unknown
NCT00002775 2014-01-06
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00004264 2013-12-04
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00821912 2012-02-28
TaxXel
Karolinska University Hospital
Phase 1/2 Unknown
NCT00448734 2009-01-21
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Poniard Pharmaceuticals
Phase 1/2 Unknown
NCT00075543 2008-07-24
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00379717 2008-03-13
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
AZ-VUB
Phase 1/2 Unknown
NCT00121095 2007-12-21
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Cytogen Corporation
Phase 1/2 Unknown